RAPT Therapeutics, Inc.
NASDAQ:RAPT
1.17 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 169.735 | 47.478 | 38.946 | 24.027 | 24.918 | 77.383 | 63.798 | 47.517 |
| Short Term Investments
| 61.32 | 111.384 | 210.122 | 165.627 | 86.592 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 231.055 | 158.862 | 249.068 | 189.654 | 111.51 | 77.383 | 63.798 | 47.517 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 4.181 | 2.92 | 3.626 | 6.638 | 8.176 | 6.246 | 1.264 | 0.725 |
| Total Current Assets
| 235.236 | 161.782 | 252.694 | 192.973 | 115.598 | 80.506 | 65.062 | 48.242 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 4.7 | 7.676 | 9.479 | 2.741 | 2.982 | 3.707 | 4.159 | 1.913 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0.598 | 0.605 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.389 | 3.871 | 4.036 | 2.922 | 0.389 | 0.389 | -0.209 | -0.369 |
| Total Non-Current Assets
| 5.089 | 11.547 | 13.515 | 5.663 | 3.371 | 4.096 | 4.548 | 2.149 |
| Total Assets
| 240.325 | 173.329 | 266.209 | 198.636 | 118.969 | 84.602 | 69.61 | 50.391 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 1.275 | 5.176 | 3.365 | 1.999 | 2.383 | 1.143 | 1.771 | 1.106 |
| Short Term Debt
| 2.422 | 2.448 | 4.342 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 1.016 | 4.096 | 4 | 0 | 0 |
| Other Current Liabilities
| 44.654 | 14.212 | 6.517 | 6.58 | 5.263 | 4.113 | 2.872 | 2.142 |
| Total Current Liabilities
| 48.351 | 21.836 | 14.224 | 9.595 | 11.742 | 9.256 | 4.643 | 3.248 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 2.07 | 4.458 | 6.819 | 0 | 0 | 0 | 0 | 108.643 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0.511 | 0.863 | 2.225 | 0.969 | 0.905 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | -162.08 | -108.643 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 2.15 | 2.185 | 2.225 | 0.969 | 0.905 |
| Total Non-Current Liabilities
| 2.07 | 4.458 | 6.819 | 2.661 | 3.048 | 2.225 | 0.969 | 109.548 |
| Total Liabilities
| 50.421 | 26.294 | 21.043 | 12.256 | 14.79 | 11.481 | 5.612 | 112.796 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 84.602 | 161.111 | 108.643 |
| Common Stock
| 0.013 | 0.003 | 0.003 | 0.003 | 0.002 | 0.002 | 0.002 | 0.001 |
| Retained Earnings
| -614.547 | -484.682 | -367.884 | -284.046 | -214.842 | -161.95 | -118.953 | -82.806 |
| Accumulated Other Comprehensive Income/Loss
| 0.05 | 0.103 | -0.026 | -0.206 | -0.177 | 0.02 | -0.004 | -3.769 |
| Other Total Stockholders Equity
| 804.388 | 631.611 | 613.073 | 470.629 | 319.196 | 235.049 | 182.954 | 24.774 |
| Total Shareholders Equity
| 189.904 | 147.035 | 245.166 | 186.38 | 104.179 | 73.121 | 63.998 | -62.405 |
| Total Equity
| 189.904 | 147.035 | 245.166 | 186.38 | 104.179 | 73.121 | 63.998 | -62.405 |
| Total Liabilities & Shareholders Equity
| 240.325 | 173.329 | 266.209 | 198.636 | 118.969 | 84.602 | 69.61 | 50.391 |